[1]张紫涵,陈 俊,徐 丹.苦参碱联合胃复春片治疗慢性萎缩性胃炎疗效及对患者血清胃蛋白酶原亚群的影响[J].陕西中医,2021,(3):323-325,333.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.013]
 ZHANG Zihan,CHEN Jun,XU Dan.Effect of matrine combined with Weifuchun tablet on efficacy and serum pepsinogen subgroup in patients with chronic atrophic gastritis[J].,2021,(3):323-325,333.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.013]
点击复制

苦参碱联合胃复春片治疗慢性萎缩性胃炎疗效及对患者血清胃蛋白酶原亚群的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年3期
页码:
323-325,333
栏目:
临床研究
出版日期:
2021-03-09

文章信息/Info

Title:
Effect of matrine combined with Weifuchun tablet on efficacy and serum pepsinogen subgroup in patients with chronic atrophic gastritis
作者:
张紫涵陈 俊徐 丹
(武汉市中西医结合医院消化内科,湖北 武汉 430000)
Author(s):
ZHANG ZihanCHEN JunXU Dan
(Department of Gastroenterology,Wuhan Integrated Chinese and Western Medicine Hospital,Wuhan 430000,China)
关键词:
慢性萎缩性胃炎 中西医结合疗法 苦参碱 胃蛋白酶原亚群 胃复春片
Keywords:
Chronic atrophic gastritis Integrated Chinese traditional and western medicine therapy Matrine Pepsinogen subgroup Weifuchun tablet
分类号:
R 573
DOI:
DOI:10.3969/j.issn.1000-7369.2020.03.013
文献标志码:
A
摘要:
目的:探讨苦参碱联合胃复春片治疗慢性萎缩性胃炎疗效及对患者血清胃蛋白酶原亚群的影响。方法:将200例慢性萎缩性胃炎患者随机分作观察组与对照组,观察组采用苦参碱联合胃复春片治疗,对照组仅采用胃复春片治疗。比较两组患者的治疗效率、症状积分、胃镜下观察情况并检测血清胃蛋白酶原亚群含量。结果:观察组患者的总有效率98.0%,高于对照组的87.0%,组间差异有统计学意义(P<0.05)。观察组患者胃酸烧心、胃脘疼痛、食欲不振等症状积分低于对照组(均P<0.05),但两组患者呃逆嗳气症状积分比较,差异无统计学意义(P>0.05)。治疗后观察组胆汁反流、糜烂、溃疡等发生率低于对照组,组间差异有统计学意义(均P<0.05); 而两组患者的出血斑发生率比较,差异无统计学意义(P>0.05)。治疗后观察组胃蛋白酶原Ⅰ(90.57±14.36)μg/L、胃蛋白酶原I/胃蛋白酶原Ⅱ(9.23±0.99),高于对照组的(63.45±12.85)μg/L、(7.56±0.82),观察组胃蛋白酶原Ⅱ(7.87±4.35)μg/L低于对照组的(9.75±4.87)μg/L,组间比较差异有统计学意义(均P<0.05)。结论:苦参碱联合胃复春片可有效缓解慢性萎缩性胃炎临床症状,改善患者血清胃蛋白酶原亚群含量。
Abstract:
Objective:To investigate the effect of matrine combined with Weifuchun tablet on efficacy and serum pepsinogen subgroup in patients with chronic atrophic gastritis.Methods:200 patients with chronic atrophic gastritis were randomly divided into observation group and control group.The observation group was treated with matrine combined with Weifuchun tablet,while the control group was only treated with Weifuchun tablet.Treatment effect,symptom score,conditions observed under gastroscope,serum pepsinogen subgroups were compared between the two groups.Results:The total effective rate of the observation group 98.0% was significantly higher than that of the control group 87.0%,difference statistically significant(P<0.05).The symptom scores of gastric acid heartburn,stomach cramps and loss of appetite in the observation group were significantly lower than those in the control group(all P<0.05),but no significant difference of hiccup between the two groups(P>0.05).After treatment,the incidence of bile reflux,erosion and ulcer in the observation group was significantly lower than those in the control group(all P<0.05).The incidence of bleeding spots in the two groups was not statistically different(P>0.05).After treatment,the levels of pepsinogen I(90.57±14.36)μg/L,pepsinogen I/pepsinogen Ⅱ(9.23±0.99)significantly higher than those in the control group(63.45±12.85)μg/L、(7.56±0.82).Pepsinogen Ⅱ in the observation group was(7.87±4.35)μg/L,significantly lower than that in the control group(9.75±4.87)μg/L,difference statistically significant(all P<0.05).Conclusion:Matrine combined with Weifuchun tablet can effectively alleviate the clinical symptoms of chronic atrophic gastritis and improve serum pepsinogen subgroups in patients.

参考文献/References:

[1] 魏 颖.慢性萎缩性胃炎胃镜下表现与病理诊断的临床对照分析[J].当代医学,2019,24(36):84-85.
[2] 魏冬琴,蒋士生.慢性萎缩性胃炎中医辨证论治研究进展[J].湖南中医杂志,2018,34(12):155-157.
[3] 朱亚楠.慢性萎缩性胃炎患者的中医证候与病理变化及幽门螺杆菌感染的相关性研究[J].现代中西医结合杂志,2018,27(36):4068-4071.
[4] 姜小艳,李京伟,张竞超,等.萎缩性胃炎致病机制研究概况及中医药实验研究进展[J].中国中西医结合消化杂志,2018,26(12):1049-1052.
[5] 朱健敏,郑亿濠,牟丽环,等.慢性萎缩性胃炎的中医治疗近况[J].广西中医药,2017,40(6):64-66.
[6] 吴水清,李达周,龚清全, 等.福建宁德地区慢性萎缩性胃炎与幽门螺旋杆菌感染情况调查研究[J].陕西医学杂志,2020,49(6):763-765,769.
[7] 陶柏桦.健脾益气方治疗慢性萎缩性胃炎的疗效及对胃黏膜组织的影响[J].中国现代医药杂志,2019,21(9):77-79.
[8] 黎 耀,孔文霞.慢性萎缩性胃炎中西医研究及中医特色治疗探讨[J].世界最新医学信息文摘,2017,17(99):218,221.
[9] 施家强,林 平.中医药治疗慢性非萎缩性胃炎临床研究进展[J].亚太传统医药,2017,13(23):65-66.
[10] 宋广飞.探讨中医辨证治疗慢性萎缩性胃炎的临床方法及疗效[J].中西医结合心血管病电子杂志,2017,5(34):157,159.
[11] 江欢欢,王翼洲.中医药治疗慢性萎缩性胃炎的研究进展[J].中国民族民间医药,2017,26(22):46-48.
[12] 徐海波,陈巧恩,陈成家.苦参碱联合胃复春片对慢性萎缩性胃炎癌前病变患者胃酸分泌功能的影响[J].世界华人消化杂志,2017,25(23):2139-2143.
[13] 周继旺,丁世玲,张卫星.叶酸片联合胃复春片治疗慢性萎缩性胃炎癌前病变疗效观察[J].新中医,2017,49(2):42-44.
[14] 陈 曦,赵亚红,张也青,等.胃复春片的临床应用和现代研究进展[J].江西中医药,2016,47(9):77-80.
[15] 姚 鹏,冯 璐,郝莉莉,等.西尼必利联合胃复春片治疗慢性萎缩性胃炎的临床研究[J].现代药物与临床,2020,35(12):2441-2445.
[16] 臧伟广.四联疗法联合胃复春对慢性萎缩性胃炎患者血清骨桥蛋白及胃泌素的影响[J].中国医药导报,2020,17(24):130-133.
[17] 何东凌,林丽梅,林春霞.胃复春片联合聚普瑞锌颗粒治疗萎缩性胃炎的疗效及对患者细胞炎症因子水平的影响[J].中国医院用药评价与分析,2017,17(5):651-652,655.
[18] 申兰国,曹志群.苦参碱联合胃复春片治疗慢性萎缩性胃炎患者的疗效研究[J].实用药物与临床,2016,19(7):883-885.
[19] 史艳平,陈 涛,李 丹,等.氧化苦参碱药理作用研究进展[J].陕西医学杂志,2018,47(2):271-273.
[20] 俞 瑾,吕 宾,黄 晨,等.血清胃蛋白酶原检测对胃癌和慢性胃炎的意义[J].中国医师进修杂志,2016,39(4):321-324.
[21] 苏泽琦,孟祥梅,于春月,等.慢性胃炎患者血清胃蛋白酶原、胃泌素表达水平与证候分布的相关性研究[J].世界中西医结合杂志,2017,12(9):1303-1306.

相似文献/References:

[1]孙明明,李 聪,史 林.王庆国教授对慢性萎缩性胃炎的治疗经验探析[J].陕西中医,2019,(2):260.
 SUN Mingming,LI Cong,SHI Lin..Analysis on the treatment experience of chronic atrophic gastritis by professor WANG Qingguo[J].,2019,(3):260.
[2]钱元霞,汤玲珺,钱 祯,等.四逆散对慢性萎缩性胃炎癌前病变大鼠的作用及机制研究*[J].陕西中医,2019,(8):990.
 QIAN Yuanxia,TANG Lingjun,QIAN Zhen,et al.The effect of Sinisan on the rats of precancerous lesion of chronic atrophic gastritis and its mechanism[J].,2019,(3):990.
[3]闫 强,杨国强 △.健脾清胃汤治疗脾胃虚弱型慢性萎缩性胃炎疗效及对患者免疫功能的影响[J].陕西中医,2019,(8):1014.
 YAN Qiang,YANG Guoqiang..Effect of Jianpi Qingwei decoction on chronic atrophic gastritis of spleen and stomach deficiency and its influence on patients' immune function[J].,2019,(3):1014.
[4]杨宏升.安胃活血汤联合序贯法治疗慢性萎缩性胃炎胃癌前病变疗效研究[J].陕西中医,2019,(9):1195.
 YANG Hongsheng..Effect of Anwei Huoxue decoction combined with sequential therapy on gastric precancerous lesions of chronic atrophic gastritis[J].,2019,(3):1195.
[5]马佳乐 ,李慧臻.中医治疗慢性萎缩性胃炎研究进展*[J].陕西中医,2019,(11):1646.
 MA Jiale,LI Huizhen..Traditional Chinese medicine in the treatment of chronic atrophic gastritis[J].,2019,(3):1646.
[6]曾微微,麦联任,张 玲,等.健胃益脾汤治疗慢性萎缩性胃炎疗效及对患者胃蛋白酶原的影响*[J].陕西中医,2020,(11):1548.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
 ZENG Weiwei,MAI Lianren,ZHANG Ling,et al.Effect of Jianwei Yipi decoction on treating chronic atrophic gastritis and its influence on pepsinogen[J].,2020,(3):1548.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
[7]王 阳.基于络病理论探析慢性萎缩性胃炎“气络失和,毒损血络”病机*[J].陕西中医,2020,(11):1632.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.030]
 WANG Yang..Analysis of pathogenesis of chronic atrophic gastritis based on collateral disease theory[J].,2020,(3):1632.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.030]
[8]蒋春波,於佳炜,林 静,等.肾炎1号方联合西药治疗肾病综合征疗效及对患者凝血指标、免疫功能的影响*[J].陕西中医,2020,(12):1743.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
 JIANG Chunbo,YU Jiawei,LIN Jing,et al.Clinical efficacy of Shenyan 1 recipe combined with western medicine in treatment of nephritic syndrome and effect on coagulation and immunity[J].,2020,(3):1743.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
[9]寇 媛,闻新丽,薛 峰.养胃清热化瘀汤治疗慢性萎缩性胃炎及癌前病变临床研究[J].陕西中医,2021,(9):1233.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]
 KOU Yuan,WEN Xinli,XUE Feng.Clinical study on Yangwei Qingre Huayu decoction in treatment of chronic atrophic gastritis and precancerous lesions[J].,2021,(3):1233.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]
[10]张 鹏,于 勇,万 强,等.补虚养胃汤加减治疗慢性萎缩性胃炎疗效及对患者胃肠功能的影响[J].陕西中医,2022,(1):66.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.016]

更新日期/Last Update: 2021-03-08